Back to Search
GREGORY PASTORES, M.D.
Neurology Physician
NPI: 1720072432Individual
Specialties, Licenses & Credentials
Neurology PhysicianPrimary
Psychiatry & Neurology — Neurology
Code: 2084N0400X
179260(NY)
Research & Publications (20)
To see a world in a grain of sand: elucidating the pathophysiology of Anderson-Fabry disease through investigations of a cellular model.
PMID 19180148·Kidney Int·2009
7-preclinical
Goal-oriented therapy with miglustat in Gaucher disease.
PMID 19210136·Curr Med Res Opin·2009
6-review
Laronidase (Aldurazyme): enzyme replacement therapy for mucopolysaccharidosis type I.
PMID 18549329·Expert Opin Biol Ther·2008
6-review
Musculoskeletal complications encountered in the lysosomal storage disorders.
PMID 19028373·Best Pract Res Clin Rheumatol·2008
6-review
Safety and pharmacokinetics of agalsidase alfa in patients with Fabry disease and end-stage renal disease.
PMID 17395657·Nephrol Dial Transplant·2007
3-trial
The MPS I registry: design, methodology, and early findings of a global disease registry for monitoring patients with Mucopolysaccharidosis Type I.
PMID 17336562·Mol Genet Metab·2007
8-other
Effect of miglustat on bone disease in adults with type 1 Gaucher disease: a pooled analysis of three multinational, open-label studies.
PMID 17919546·Clin Ther·2007
8-other
Miglustat: substrate reduction therapy for lysosomal storage disorders associated with primary central nervous system involvement.
PMID 18221193·Recent Pat CNS Drug Discov·2006
6-review
Management of patients with Gaucher's disease: Clinical perspectives.
PMID 17011473·Eur J Intern Med·2006
8-other
A chaperone-mediated approach to enzyme enhancement as a therapeutic option for the lysosomal storage disorders.
PMID 17073517·Drugs R D·2006
6-review
An open-label, noncomparative study of miglustat in type I Gaucher disease: efficacy and tolerability over 24 months of treatment.
PMID 16199246·Clin Ther·2005
3-trial
Current and emerging therapies for the lysosomal storage disorders.
PMID 16262569·Expert Opin Emerg Drugs·2005
6-review
Musculoskeletal complications associated with lysosomal storage disorders: Gaucher disease and Hurler-Scheie syndrome (mucopolysaccharidosis type I).
PMID 15604908·Curr Opin Rheumatol·2005
6-review
Substrate reduction therapy: miglustat as a remedy for symptomatic patients with Gaucher disease type 1.
PMID 12556220·Expert Opin Investig Drugs·2003
6-review
A neurological symptom survey of patients with type I Gaucher disease.
PMID 14707512·J Inherit Metab Dis·2003
8-other
Advances in the management of Anderson-Fabry disease: enzyme replacement therapy.
PMID 11890871·Expert Opin Biol Ther·2002
6-review
Biochemical and molecular genetic basis of Fabry disease.
PMID 12068024·J Am Soc Nephrol·2002
6-review
Bone and joint complications related to Gaucher disease.
PMID 11123056·Curr Rheumatol Rep·2000
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 403 E 34TH ST, 2ND FL
NEW YORK, NY 10016 - Phone
- (212) 263-8344
Quick Facts
- NPI
- 1720072432
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile